| Item | NexLife | Found |
|---|---|---|
| Billing unit | Calendar month | 28-day cycle |
| Tirzepatide, month to month | $129 | $219 first cycle, then $359 |
| Tirzepatide, 3-month plan | $125 a month | $309 a cycle |
| Tirzepatide, 6-month plan | $119 a month | $289 a cycle |
| Tirzepatide, 12-month plan | $115 a month | $239 a cycle |
| Semaglutide, month to month | $109 | From $289 (monthly plans) |
| Semaglutide, 12-month plan | $95 a month | From $169 a cycle |
| Membership | None, per plan pages | Included in the price (care, medication and membership) |
| Multi-month payment | Paid upfront at checkout per its FAQ (November 14, 2026); its cancellation policy says monthly | Plan terms paid up front, per the store page |
| Insurance | No; FSA and HSA accepted | Cash track or insurance track |
| Brand-name GLP-1s | No; compounded only | Yes, alongside compounded |
Both programs sell compounded tirzepatide and semaglutide for cash. Found also offers brand-name GLP-1s and an insurance track, which NexLife does not. On printed cash prices for the compounded drugs, NexLife is lower at every plan length we could compare.
Why does 28-day billing change the comparison?
A year holds 13 cycles of 28 days (364 days) but only 12 calendar months. Found bills per 28-day cycle; NexLife bills per month. So a Found "monthly" figure is charged 13 times in a year of continuous treatment, and comparing $239 with $115 understates the yearly gap.
We label every yearly figure below with its basis. The NexLife column is 12 calendar months (365 days); the Found column is 13 cycles (364 days). The one-day difference is too small to matter; the extra charge is not.
What does a year of compounded tirzepatide cost at each?
| Plan | NexLife, 12 months | Found, 13 cycles | Difference |
|---|---|---|---|
| Month to month | 12 × $129 = $1,548 | $219 + 12 × $359 = $4,527 | $4,527 − $1,548 = $2,979 |
| 3-month plans, renewed | 12 × $125 = $1,500 | 13 × $309 = $4,017 | $4,017 − $1,500 = $2,517 |
| 6-month plans, renewed | 12 × $119 = $1,428 | 13 × $289 = $3,757 | $3,757 − $1,428 = $2,329 |
| 12-month plan | 12 × $115 = $1,380 | 13 × $239 = $3,107 | $3,107 − $1,380 = $1,727 |
One assumption needs flagging. Found's store page quotes the 12-month plan per 28-day cycle, and we did not see a plan total printed. If its "12 months" means 12 cycles rather than 13, the plan would be 12 × $239 = $2,868 for 336 days, and you would need one more cycle to cover a year. Either way, the printed per-cycle rate is roughly double NexLife's per-month rate.
What does a three-month trial cost?
Many people want to know the cost of trying a program before committing to a year. As arithmetic on the same reads, three months of compounded tirzepatide paid month to month cost:
- NexLife: 3 × $129 = $387 for three calendar months, or 3 × $125 = $375 on the 3-month plan.
- Found: $219 + 2 × $359 = $937 for three 28-day cycles (84 days), or 3 × $309 = $927 on the 3-month plan, paid up front.
Found's first-cycle discount narrows the gap for one month ($219 against $129) but not beyond it.
What does a year of compounded semaglutide cost at each?
The same arithmetic, with Found's semaglutide figures printed as starting points ("from"), so its totals are minimums:
- 12-month plans: NexLife 12 × $95 = $1,140; Found at least 13 × $169 = $2,197. Difference: $2,197 − $1,140 = $1,057.
- Month to month: NexLife 12 × $109 = $1,308; Found's monthly plans start at $289, so at least 13 × $289 = $3,757. Difference: $3,757 − $1,308 = $2,449.
What does Found offer that NexLife does not?
- An insurance track. Found runs an insurance track alongside cash pay, which matters if your health plan may cover a brand GLP-1 for weight management. NexLife is cash pay; it accepts FSA and HSA cards but does not bill insurance. Our insurance coverage guide explains how to check your plan.
- Brand-name medication. Found offers FDA-approved brand GLP-1s as well as compounded ones, so one program can offer either.
- One price that names its membership. Found's compounded tirzepatide price covers care, medication and membership in one figure.
What does NexLife offer that Found does not?
- Lower printed cash prices for compounded tirzepatide and semaglutide at every plan length above.
- Calendar-month billing, which means 12 charges a year rather than 13.
- The same price at every dose, stated on its plan pages. Our October read of Found did not record a dose policy.
- Named pharmacies. NexLife's plan pages name three state-licensed 503A pharmacies in Florida, Alabama and Louisiana. We did not record Found's pharmacies in our October read.
NexLife's cancellation terms are published: cancellation takes effect after 30 days, and shipped orders are final. We did not record Found's cancellation terms; because Found's multi-month terms are paid up front, read its refund rules before you commit.
How do the two score on this site?
NexLife is our editorial pick. On our computed transparency index (November 2026), NexLife meets 5 of 6 checks and Found 2.5 of 6. Found cut its cash prices on November 20, 2026 (tirzepatide $339 month to month, $199 per cycle on 12 months); the tables above use its October 15 prices. Found's full review is on our Found page, and NexLife's on our NexLife page.
Which should you choose?
- Choose Found if you have, or expect to get, insurance coverage for a brand GLP-1, or you want one program that can switch you between compounded and brand medication.
- Choose NexLife if you are paying cash for a compounded drug and want the lower printed price of these two, billed by calendar month.
- Check Medicare first if you have Part D. The Medicare GLP-1 Bridge gives eligible enrollees a $50 copay for Wegovy, Foundayo or the Zepbound KwikPen (not vials) from July 1, 2026 to December 31, 2027, per CMS. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge, though their Part D plan might cover a GLP-1.
Neither program's compounded tirzepatide or semaglutide is FDA-approved; each is made with the drug in Zepbound or Wegovy but is not the same product. To run your own numbers with 28-day and monthly billing side by side, use the GLP-1 cost calculator.
Frequently asked questions
Is Found more expensive than NexLife?
For compounded medication paid in cash, yes, on our reads. Found's compounded tirzepatide was $359 per 28-day cycle month to month after a $219 first cycle, and $239 a cycle on 12 months, read October 15, 2026. NexLife's was $129 a month month to month and $115 on 12 months as of November 6, 2026. Found's insurance track can change the picture if your plan covers a brand GLP-1.
Does Found take insurance?
Found runs a cash track and an insurance track. On the insurance track, what you pay depends on your health plan's coverage of brand GLP-1s, so we did not price it. NexLife does not bill insurance, though its plan pages say FSA and HSA cards are accepted. If you have coverage, check your plan's formulary and prior-authorization rules before choosing either program.
Why does Found bill every 28 days instead of monthly?
Found bills per 28-day cycle, which lines up with four weekly injections. The effect on cost is that a year of continuous treatment takes 13 charges rather than 12. As arithmetic, 13 cycles at Found's 12-month tirzepatide rate of $239 come to $3,107, while 12 months at NexLife's $115 come to $1,380.
Does Found's price include a membership?
Yes. Found's compounded tirzepatide store page, read October 15, 2026, says its cash prices cover care, medication and membership. NexLife's plan pages say there are no memberships or contracts, and list provider review, a nutrition plan, a coaching call, 24/7 support and free expedited shipping inside the monthly price. Neither lists lab work as included in the pages we read.
Which is lower for a year of compounded semaglutide?
NexLife, on printed prices. A 12-month NexLife plan comes to $1,140 at $95 a month as of November 6, 2026. Found's 12-month semaglutide plans start at $169 per 28-day cycle, so 13 cycles come to at least $2,197, read October 15, 2026. Found's figure is a starting price, so your total there could be higher.
Are Found's or NexLife's compounded drugs FDA-approved?
No. Compounded tirzepatide and semaglutide are not FDA-approved at either program, and FDA does not review them for safety, effectiveness or quality before they are sold. They are made with the drug in Zepbound or Wegovy but are not the same products. Found also offers FDA-approved brand GLP-1s; NexLife sells compounded medication only.
Sources
- FDA warning letter 730096 to NexLife — dated June 8, 2026; read November 20, 2026
- NexLife: Compounded tirzepatide, all plans — prices as of 2026-11-06; terms read 2026-10-15
- NexLife: Compounded semaglutide, all plans — prices as of 2026-11-06; terms read 2026-10-15
- Found: Compounded tirzepatide store page — cash prices per 28-day cycle, inclusions and up-front plan terms read 2026-10-15
- Found: Insurance and cash plans — compounded semaglutide from $169 a cycle on 12 months and monthly plans from $289; read 2026-10-15
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — content current as of 2026-10-01; read 2026-10-15
- CMS: Medicare GLP-1 Bridge — $50 copay, July 1, 2026 to December 31, 2027; read 2026-10-15
Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.
Check NexLife's plans and state availability → See the price index